If you want to build a balanced portfolio, having a few blue chip ASX 200 shares could be a smart move. But with so many to choose from, it can be hard to decide which ones to buy.
To narrow things down for you, I have picked out two ASX blue chip shares that are highly rated:
Goodman Group (ASX: GMG)
The first blue chip ASX 200 share to look at is Goodman Group. It is a leading integrated commercial and industrial property company with operations across the world. Among its portfolio are warehouses, data centres, large scale logistics facilities, and business and office parks.
Goodman currently has $62 billion of total assets under management and over 1,600 customers globally. Among the latter are the likes of Amazon, Coles Group Ltd (ASX: COL), DHL, Showpo, and Walmart.
Demand for its properties has been strong and has underpinned sky high occupancy rates and stellar earnings growth over the last decade.
This demand is being driven by the success of Goodman's strategy. That strategy has seen the company develop modern, high quality properties in key gateway cities around the world. It notes that this has shortened the distance between businesses and consumers and put its customers ahead of the market.
Morgan Stanley has been impressed with Goodman's performance and appears confident its positive form can continue. It has an overweight rating and $26.50 price target on Goodman's shares.
Sonic Healthcare Limited (ASX: SHL)
Another ASX 200 blue chip share to consider is Sonic. It is one of the world's leading healthcare providers with operations in Australasia, Europe and North America.
Sonic currently employs more than 1,500 pathologists and radiologists, and more than 10,000 medical scientists, radiographers, sonographers, technicians, and nurses.
This strong network, and particularly its pathology business, has allowed the company to thrive during the last two years while many other healthcare companies have struggled. This has been due to its exposure to COVID testing and the resilient performance of its non-COVID testing businesses.
One broker that has been very impressed is Morgans. It remains confident on its outlook and currently has an add rating and $45.98 price target on Sonic's shares.
